Is it your opinion that this recent announcement by Alcon to initiate the Retanne study could impact (good or bad) current interest in "big pharma" signing a deal with GENR?
BTW ...I share your opinion with respect to Merck and their need to look at companies like GENR if they want to compete with other big drug companies.
News 
Market Data 
Discover 
